FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892718794> ?p ?o ?g. }

• W2892718794 endingPage "2915" @default.
• W2892718794 startingPage "2915" @default.
• W2892718794 abstract "Salvage chemotherapy for refractory metastatic colorectal cancer using trifluridine/tipiracil (FTD/TPI) and regorafenib has shown survival benefits. We evaluated the antitumor effects of FTD or FTD/TPI combined with regorafenib in vitro and in vivo. SW620, HCT 116, and HT-29 human colorectal cancer cell lines were treated with FTD and regorafenib simultaneously and sequentially. Cell death, incorporation of FTD into DNA, and molecules related to FTD and regorafenib-associated cell death were investigated. The antitumor effects of FTD combined with regorafenib in SW620 and COLO205 xenografts were also evaluated. Cell death was greater after sequential treatment with FTD followed by regorafenib in SW620 cells, but not in HCT 116 and HT-29 cells, than after treatment with FTD alone, which was attributable to thymidylate synthase reduction with the induction of apoptosis. In contrast, simultaneous and sequential exposure to regorafenib followed by FTD, but not FTD alone, attenuated the cell death effect. Furthermore, combined FTD/TPI treatment followed by regorafenib had greater antitumor activity than either monotherapy in SW620 and COLO205 xenograft models. Treatment results following regorafenib administration subsequent to FTD or FTD/TPI suggest that sequential therapy with FTD/TPI prior to regorafenib may be effective in a clinical setting." @default.
• W2892718794 created "2018-10-05" @default.
• W2892718794 creator A5006904110 @default.
• W2892718794 creator A5025498957 @default.
• W2892718794 creator A5051132319 @default.
• W2892718794 creator A5058238996 @default.
• W2892718794 creator A5063161716 @default.
• W2892718794 creator A5073764534 @default.
• W2892718794 date "2018-09-25" @default.
• W2892718794 modified "2023-09-27" @default.
• W2892718794 title "Effective Sequential Combined Chemotherapy with Trifluridine/Tipiracil and Regorafenib in Human Colorectal Cancer Cells" @default.
• W2892718794 cites W1504814099 @default.
• W2892718794 cites W1963576363 @default.
• W2892718794 cites W1968209756 @default.
• W2892718794 cites W1969825132 @default.
• W2892718794 cites W1980850901 @default.
• W2892718794 cites W1994265946 @default.
• W2892718794 cites W2017800701 @default.
• W2892718794 cites W2021102443 @default.
• W2892718794 cites W2028995105 @default.
• W2892718794 cites W2045370737 @default.
• W2892718794 cites W2053662276 @default.
• W2892718794 cites W2094052679 @default.
• W2892718794 cites W2101132650 @default.
• W2892718794 cites W2127497086 @default.
• W2892718794 cites W2139002359 @default.
• W2892718794 cites W2141766149 @default.
• W2892718794 cites W2147834058 @default.
• W2892718794 cites W2313619865 @default.
• W2892718794 cites W2346422562 @default.
• W2892718794 cites W242040007 @default.
• W2892718794 cites W2508731920 @default.
• W2892718794 cites W2552576838 @default.
• W2892718794 cites W2613038127 @default.
• W2892718794 cites W2754547251 @default.
• W2892718794 cites W2789450032 @default.
• W2892718794 doi "https://doi.org/10.3390/ijms19102915" @default.
• W2892718794 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6213129" @default.
• W2892718794 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30257515" @default.
• W2892718794 hasPublicationYear "2018" @default.
• W2892718794 type Work @default.
• W2892718794 sameAs 2892718794 @default.
• W2892718794 citedByCount "9" @default.
• W2892718794 countsByYear W28927187942019 @default.
• W2892718794 countsByYear W28927187942020 @default.
• W2892718794 countsByYear W28927187942021 @default.
• W2892718794 countsByYear W28927187942022 @default.
• W2892718794 countsByYear W28927187942023 @default.
• W2892718794 crossrefType "journal-article" @default.
• W2892718794 hasAuthorship W2892718794A5006904110 @default.
• W2892718794 hasAuthorship W2892718794A5025498957 @default.
• W2892718794 hasAuthorship W2892718794A5051132319 @default.
• W2892718794 hasAuthorship W2892718794A5058238996 @default.
• W2892718794 hasAuthorship W2892718794A5063161716 @default.
• W2892718794 hasAuthorship W2892718794A5073764534 @default.
• W2892718794 hasBestOaLocation W28927187941 @default.
• W2892718794 hasConcept C121608353 @default.
• W2892718794 hasConcept C126322002 @default.
• W2892718794 hasConcept C143998085 @default.
• W2892718794 hasConcept C190283241 @default.
• W2892718794 hasConcept C2776248978 @default.
• W2892718794 hasConcept C2776694085 @default.
• W2892718794 hasConcept C31573885 @default.
• W2892718794 hasConcept C502942594 @default.
• W2892718794 hasConcept C526805850 @default.
• W2892718794 hasConcept C55493867 @default.
• W2892718794 hasConcept C71924100 @default.
• W2892718794 hasConcept C86803240 @default.
• W2892718794 hasConcept C98274493 @default.
• W2892718794 hasConceptScore W2892718794C121608353 @default.
• W2892718794 hasConceptScore W2892718794C126322002 @default.
• W2892718794 hasConceptScore W2892718794C143998085 @default.
• W2892718794 hasConceptScore W2892718794C190283241 @default.
• W2892718794 hasConceptScore W2892718794C2776248978 @default.
• W2892718794 hasConceptScore W2892718794C2776694085 @default.
• W2892718794 hasConceptScore W2892718794C31573885 @default.
• W2892718794 hasConceptScore W2892718794C502942594 @default.
• W2892718794 hasConceptScore W2892718794C526805850 @default.
• W2892718794 hasConceptScore W2892718794C55493867 @default.
• W2892718794 hasConceptScore W2892718794C71924100 @default.
• W2892718794 hasConceptScore W2892718794C86803240 @default.
• W2892718794 hasConceptScore W2892718794C98274493 @default.
• W2892718794 hasIssue "10" @default.
• W2892718794 hasLocation W28927187941 @default.
• W2892718794 hasLocation W28927187942 @default.
• W2892718794 hasLocation W28927187943 @default.
• W2892718794 hasLocation W28927187944 @default.
• W2892718794 hasOpenAccess W2892718794 @default.
• W2892718794 hasPrimaryLocation W28927187941 @default.
• W2892718794 hasRelatedWork W2291195808 @default.
• W2892718794 hasRelatedWork W2513543904 @default.
• W2892718794 hasRelatedWork W2516833820 @default.
• W2892718794 hasRelatedWork W2592898585 @default.
• W2892718794 hasRelatedWork W2940357394 @default.
• W2892718794 hasRelatedWork W2999793536 @default.
• W2892718794 hasRelatedWork W3030758306 @default.
• W2892718794 hasRelatedWork W3203415798 @default.
• W2892718794 hasRelatedWork W861557199 @default.

• next